7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Liver Regeneration after Hepatectomy and Partial Liver Transplantation

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The liver is a unique organ with an abundant regenerative capacity. Therefore, partial hepatectomy (PHx) or partial liver transplantation (PLTx) can be safely performed. Liver regeneration involves a complex network of numerous hepatotropic factors, cytokines, pathways, and transcriptional factors. Compared with liver regeneration after a viral- or drug-induced liver injury, that of post-PHx or -PLTx has several distinct features, such as hemodynamic changes in portal venous flow or pressure, tissue ischemia/hypoxia, and hemostasis/platelet activation. Although some of these changes also occur during liver regeneration after a viral- or drug-induced liver injury, they are more abrupt and drastic following PHx or PLTx, and can thus be the main trigger and driving force of liver regeneration. In this review, we first provide an overview of the molecular biology of liver regeneration post-PHx and -PLTx. Subsequently, we summarize some clinical conditions that negatively, or sometimes positively, interfere with liver regeneration after PHx or PLTx, such as marginal livers including aged or fatty liver and the influence of immunosuppression.

          Related collections

          Most cited references152

          • Record: found
          • Abstract: found
          • Article: not found

          NF-κB, inflammation, immunity and cancer: coming of age

          Fourteen years have passed since nuclear factor-κB (NF-κB) was first shown to serve as a molecular lynchpin that links persistent infections and chronic inflammation to increased cancer risk. The young field of inflammation and cancer has now come of age, and inflammation has been recognized by the broad cancer research community as a hallmark and cause of cancer. Here, we discuss how the initial discovery of a role for NF-κB in linking inflammation and cancer led to an improved understanding of tumour-elicited inflammation and its effects on anticancer immunity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            RAS Proteins and Their Regulators in Human Disease.

            RAS proteins are binary switches, cycling between ON and OFF states during signal transduction. These switches are normally tightly controlled, but in RAS-related diseases, such as cancer, RASopathies, and many psychiatric disorders, mutations in the RAS genes or their regulators render RAS proteins persistently active. The structural basis of the switch and many of the pathways that RAS controls are well known, but the precise mechanisms by which RAS proteins function are less clear. All RAS biology occurs in membranes: a precise understanding of RAS' interaction with membranes is essential to understand RAS action and to intervene in RAS-driven diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Mechanisms of Hippo pathway regulation

              In this review, Meng et al. focus on recent developments in our understanding of the molecular actions of the core Hippo kinase cascade and discuss key open questions in Hippo pathway regulation and function.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                09 November 2020
                November 2020
                : 21
                : 21
                : 8414
                Affiliations
                Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan; mhirata6341@ 123456kuhp.kyoto-u.ac.jp (M.H.); yo_miyachi@ 123456kuhp.kyoto-u.ac.jp (Y.M.); uemoto@ 123456kuhp.kyoto-u.ac.jp (S.U.)
                Author notes
                [* ]Correspondence: shintaro@ 123456kuhp.kyoto-u.ac.jp ; Tel.: +81-75-751-3242
                Author information
                https://orcid.org/0000-0001-7465-5761
                Article
                ijms-21-08414
                10.3390/ijms21218414
                7665117
                33182515
                a2f3056c-72a8-4cd6-a8ba-9d08eeecf938
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 12 October 2020
                : 05 November 2020
                Categories
                Review

                Molecular biology
                liver regeneration,hepatectomy,liver transplantation
                Molecular biology
                liver regeneration, hepatectomy, liver transplantation

                Comments

                Comment on this article